You are here

clinical trials

FDA mandates pediatric trials for 200 cancer targets

FDA mandates pediatric trials for 200 cancer targets

BioCentury

clinical trials

Flag link:

ICER weighing issuing advice on trial design

ICER weighing issuing advice on trial design

BioCentury

clinical trials

Flag link:

Public seems to know value of clinical trials, but not how they work

Public seems to know value of clinical trials, but not how they work

Reuters

clinical trials

Flag link:

Bristol-Myers Squibb's Opdivo Misses Primary Endpoint in Ph III Study in Small Cell Lung Cancer

Bristol-Myers Squibb's Opdivo Misses Primary Endpoint in Ph III Study in Small Cell Lung Cancer

CP Wire

Bristol-Myers Squibb

Small-Cell Lung Cancer

clinical trials

Flag link:

Bristol-Myers to invest in Compugen, collaborate in clinical trials

Bristol-Myers to invest in Compugen, collaborate in clinical trials

Yahoo/Reuters

Bristol-Myers Squibb

clinical trials

Flag link:

The Importance of Diversity in Clinical Trials (Because Right Now, It's Lacking)

The Importance of Diversity in Clinical Trials (Because Right Now, It's Lacking)

BioSpace

clinical trials

Flag link:

UK clinical trials fall as Brexit clouds drug approval process

UK clinical trials fall as Brexit clouds drug approval process

Reuters

clinical trials

Flag link:

Peninsula biotech coughs up 40 percent of its value on failed clinical trial

Peninsula biotech coughs up 40 percent of its value on failed clinical trial

Bizjournals.com

clinical trials

Menlo Therapeutics

Flag link:

A double date with destiny for Alkermes

A double date with destiny for Alkermes

EP Vantage

clinical trials

Flag link:

Xencor’s lead drug fails a PhII test for lupus, shares slide

Xencor’s lead drug fails a PhII test for lupus, shares slide

Endpoints

clinical trials

Flag link:

UK alarm bells are ringing as a biotech cuts a few trial sites, fretting over Brexit’s impact on drug development

UK alarm bells are ringing as a biotech cuts a few trial sites, fretting over Brexit’s impact on drug development

Endpoints

clinical trials

Flag link:

Bausch Health announces good Phase III results from psoriasis therapy

Bausch Health announces good Phase III results from psoriasis therapy

GoinPharma

clinical trials

Flag link:

Clinical Trials: FDA Releases Two Draft Guidances

Clinical Trials: FDA Releases Two Draft Guidances

RAPS.org

clinical trials

Flag link:

Are Clinical Trials Really That Costly? These Researchers Say They Don’t Have to Be

Are Clinical Trials Really That Costly? These Researchers Say They Don’t Have to Be

Xtalks

clinical trials

Flag link:

Aldeyra plans reproxalap phase 3 after wrapping up dry eye disease trial

Aldeyra plans reproxalap phase 3 after wrapping up dry eye disease trial

Fierce Biotech

Aldeyra Therapeutics

dry eye disease

clinical trials

Flag link:

Reata’s bardoxolone hits goals in phase 2 kidney disease trial

Reata’s bardoxolone hits goals in phase 2 kidney disease trial

Fierce Biotech

clinical trials

Flag link:

J&J's Esketamine Fails to Meet Endpoint in Phase III Study

J&J's Esketamine Fails to Meet Endpoint in Phase III Study

Yahoo/Zacks.com

clinical trials

treatment-resistant depression

Flag link:

Phase 3 Trial Costs Estimated at $19M, Study Finds

Phase 3 Trial Costs Estimated at $19M, Study Finds

RAPS.org

clinical trials

Flag link:

Alexion’s Soliris wows in rare disease PhIII trial, opening up a new franchise worth $500M-$700M

Alexion’s Soliris wows in rare disease PhIII trial, opening up a new franchise worth $500M-$700M

Endpoints

clinical trials

Flag link:

Farxiga Meets One Primary Endpoint in Large Ph III Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes

Farxiga Meets One Primary Endpoint in Large Ph III Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes

CP Wire

clinical trials

type 2 diabetes

cardiovascular disease

Flag link:

Pages